EATG » Phase 3 registrational data is not sufficient for roll-out of new ARVs in LMICs

Phase 3 registrational data is not sufficient for roll-out of new ARVs in LMICs

Phase 3 randomised trials for drug approval in high-income countries do not provide sufficient evidence to support the widespread use of new antiretrovirals in low- and middle-income countries (LMICs), where the majority of people with HIV live.

Read the full article here.

Source:
HIV i-Base
News categories: HIV treatment